Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Department of Radiology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
J Cardiothorac Vasc Anesth. 2021 Dec;35(12):3642-3651. doi: 10.1053/j.jvca.2021.02.008. Epub 2021 Feb 6.
To determine the incidence, predictors, and outcome of pneumothorax (PNX)/pneumomediastinum (PMD) in coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS).
Observational study.
Tertiary-care university hospital.
One hundred sixteen consecutive critically ill, invasively ventilated patients with COVID-19 ARDS.
The authors collected demographic, mechanical ventilation, imaging, laboratory, and outcome data. Primary outcome was the incidence of PNX/PMD. Multiple logistic regression analyses were performed to identify predictors of PNX/PMD.
PNX/PMD occurred in a total of 28 patients (24.1%), with 22 patients developing PNX (19.0%) and 13 developing PMD (11.2%). Mean time to development of PNX/PMD was 14 ± 11 days from intubation. The authors found no significant difference in mechanical ventilation parameters between patients who developed PNX/PMD and those who did not. Mechanical ventilation parameters were within recommended limits for protective ventilation in both groups. Ninety-five percent of patients with PNX/PMD had the Macklin effect (linear collections of air contiguous to the bronchovascular sheaths) on a baseline computed tomography scan, and tended to have a higher lung involvement at intensive care unit (ICU) admission (Radiographic Assessment of Lung Edema score 32.2 ± 13.4 v 18.7 ± 9.8 in patients without PNX/PMD, p = 0.08). Time from symptom onset to intubation and time from total bilirubin on day two after ICU admission were the only independent predictors of PNX/PMD. Mortality was 60.7% in patients who developed PNX/PMD versus 38.6% in those who did not (p = 0.04).
PNX/PMD occurs frequently in COVID-19 patients with ARDS requiring mechanical ventilation, and is associated with increased mortality. Development of PNX/PMD seems to occur despite use of protective mechanical ventilation and has a radiologic predictor sign.
确定 2019 年冠状病毒病(COVID-19)急性呼吸窘迫综合征(ARDS)患者中气胸(PNX)/纵隔气肿(PMD)的发生率、预测因素和结局。
观察性研究。
三级保健大学医院。
116 例连续接受有创机械通气治疗的 COVID-19 ARDS 危重症患者。
作者收集了人口统计学、机械通气、影像学、实验室和结局数据。主要结局是 PNX/PMD 的发生率。进行了多变量逻辑回归分析以确定 PNX/PMD 的预测因素。
共有 28 例患者(24.1%)发生 PNX/PMD,其中 22 例患者发生 PNX(19.0%),13 例患者发生 PMD(11.2%)。从插管到发生 PNX/PMD 的中位时间为 14±11 天。作者发现发生 PNX/PMD 与未发生 PNX/PMD 的患者之间的机械通气参数无显著差异。两组患者的机械通气参数均在保护性通气的推荐范围内。95%的 PNX/PMD 患者在基线 CT 扫描上存在 Macklin 效应(与支气管血管鞘相邻的线性空气积聚),且在入住 ICU 时肺部受累程度更高(肺部水肿评分分别为 32.2±13.4 和 18.7±9.8,p=0.08)。从症状出现到插管的时间以及 ICU 入院后第 2 天总胆红素的时间是发生 PNX/PMD 的唯一独立预测因素。发生 PNX/PMD 的患者死亡率为 60.7%,未发生 PNX/PMD 的患者死亡率为 38.6%(p=0.04)。
需要机械通气的 COVID-19 患者中 PNX/PMD 发生率高,且与死亡率增加相关。尽管采用了保护性机械通气,PNX/PMD 的发生似乎仍有预测因素,且具有放射学预测指标。